Want to see SNDL full AI Analyst Report?
SNDL Stock Chart & Stats
$1.35
>-$0.01(-0.40%)
At close: 4:00 PM EDT
$1.35
>-$0.01(-0.40%)
Day’s Range― - ―
52-Week Range$1.17 - $2.89
Previous CloseN/A
Volume1.71M
Average Volume (3M)1.37M
Market Cap
$347.03M
Enterprise Value$320.28
Total Cash (Recent Filing)$186.57M
Total Debt (Recent Filing)$166.38M
Price to Earnings (P/E)―
Beta0.55
Next Earnings
Nov 10, 2026EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding246,120,850
10 Day Avg. Volume1,460,750
30 Day Avg. Volume1,367,280
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)0.53
Price to Sales (P/S)0.62
P/FCF Ratio10.12
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$3.50Price Target Upside159.26% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.02
Revenue Forecast (FY)$921.96M
Bulls Say, Bears Say
Bulls Say
Conservative LeverageDebt-to-equity of about 0.15 and multiple years of relatively low debt give SNDL financial flexibility while it funds operations, strategic investments, or capital returns. This conservative structure reduces balance-sheet strain, although it has not yet translated into positive returns.
Positive Cash GenerationTTM operating cash flow of $64.2M and free cash flow of $50.6M show that the business has improved its ability to generate cash versus earlier years. That cash can support investment and resilience over the next several quarters, even though the sharp FCF growth decline signals volatility.
U.S. Medical Cannabis ExpansionCompletion of the Parallel asset deal adds a sizable U.S. medical-cannabis platform, including 56 stores and three production sites, to SNDL's strategic footprint. If required approvals and direct control are achieved, the deal could broaden geographic reach and create a larger platform for revenue growth.
Bears Say
Revenue ContractionTTM revenue of $928.4M contracted sharply, while Q2 consolidated revenue also fell 3.7% year over year. Persistent top-line weakness across liquor and cannabis can reduce operating leverage and makes future profit improvement dependent on execution rather than established growth.
Cannabis Margin CollapseCannabis operations gross margin fell to 1.8% as gross profit dropped to $0.6M, with the company attributing 80–90% of the shortfall to Jeeter ramp-up inefficiencies. Expected persistence in coming months creates a direct risk to near-term margins and cash conversion.
Negative ProfitabilityTTM EBIT and net margin remain negative, and Q2 reported a $7.8M operating loss plus a $7.0M adjusted operating loss. Without consistent bottom-line profitability, SNDL has less evidence that margin gains can endure and must rely more heavily on operational initiatives.
SNDL News
SNDL FAQ
What was SNDL’s price range in the past 12 months?
SNDL lowest stock price was $1.17 and its highest was $2.89 in the past 12 months.
What is SNDL’s market cap?
SNDL’s market cap is $347.03M.
When is SNDL’s upcoming earnings report date?
SNDL’s upcoming earnings report date is Nov 10, 2026 which is in 46 days.
How were SNDL’s earnings last quarter?
SNDL released its earnings results on Jul 28, 2026. The company reported -$0.022 earnings per share for the quarter, missing the consensus estimate of -$0.004 by -$0.018.
Is SNDL overvalued?
According to Wall Street analysts SNDL’s price is currently Undervalued.
Does SNDL pay dividends?
SNDL does not currently pay dividends.
What is SNDL’s EPS estimate?
SNDL’s EPS estimate is -0.01.
How many shares outstanding does SNDL have?
SNDL has 246,120,850 shares outstanding.
What happened to SNDL’s price movement after its last earnings report?
SNDL reported an EPS of -$0.022 in its last earnings report, missing expectations of -$0.004. Following the earnings report the stock price went down -9.63%.
Which hedge fund is a major shareholder of SNDL?
Currently, no hedge funds are holding shares in SNDL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SNDL Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.50 (159.26% Upside)
$3.50 (159.26% Upside)
Blogger Sentiment
Bullish
SNDL Sentiment 75%
Sector Average 63%
Sector Average 63%
Hedge Fund Trend
Decreased
By 18.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $52.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.1%
Last 30 Days ▼ 1.9%
Last 30 Days ▼ 1.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-44.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-4.53%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
SNDL
SNDL Inc. is a Canadian firm engaged in the cultivation, distribution, and sale of cannabis products across the country. Its operations are organized into two distinct segments: Cannabis Operations and Retail Operations. Through its Cannabis Operations, the company manages the growing, supplying, and selling of cannabis specifically for the adult-use market. Meanwhile, its Retail Operations segment is responsible for the direct private sale of recreational cannabis via a network of both corporate-owned and franchised retail outlets. SNDL also produces and distributes a range of inhalable cannabis products, including dried flower, pre-rolled joints, and vape cartridges. These items are marketed under several key brands, such as Top Leaf, Sundial Cannabis, Palmetto, and Grasslands. The company, originally incorporated in 2006 as Sundial Growers Inc., officially adopted its current name, SNDL Inc., in July 2022. Its main corporate office is situated in Calgary, Canada.
SNDL Company Deck
SNDL Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The quarter presented a mixed picture: operational performance was challenged with declines in revenue, gross profit and segment-level profitability (notably in cannabis operations and liquor retail), driven by market softness and production ramp inefficiencies (Jeeter). Offsetting these headwinds, SNDL entered transformational capital and strategic positions — strong liquidity (CAD 183.2M), zero debt, accelerated share repurchases (~7% reduction in shares outstanding), deployment of profit enhancement initiatives (>CAD 20M expected), modest improvement in free cash flow, and the completion of a major parallel restructuring milestone that opens access to a sizeable U.S. medical cannabis platform with material upside. Given substantial near-term operational challenges balanced against meaningful balance sheet strength and strategic optionality, the call’s tone is cautiously constructive but mixed.View all SNDL earnings summariesSNDL Stock 12 Month Forecast
Average Price Target
$3.50
▲(159.26% Upside)
Technical Analysis
Ownership Overview
2.54% Insiders
0.22% Mutual Funds
5.28% Other Institutional Investors
88.68% Public Companies and
Individual Investors